Recebe mais respostas dos empregadores
Envia um currículo específico para a oferta em poucos minutos.
AMGEN in Lisbon, Portugal, invites an experienced Transfer Pricing Manager to lead the global documentation lifecycle. You will own the OECD Master File, local country files, and related reports, partnering with Finance, Legal, and business stakeholders to reflect evolving operations in TP documentation.
You will drive governance, data-driven analyses, and AI-enabled improvements; expect interaction with regional teams and advisory partners to maintain robust risk management and compliance
Join our team at AMGEN Capability Center Portugal, consistently recognized among the top companies in the Best Workplaces ranking by Great Place to Work in Portugal. In 2026, we were once again distinguished as one of the top Best Workplaces in the country (category 201-500 employees), reinforcing our commitment to an exceptional employee experience and workplace culture. We are a team of over 600 talented individuals, spanning more than 30 functions and areas of expertise, and representing over 40 nationalities. Together, we bring diverse perspectives and professional backgrounds to help shape the future of healthcare through innovation and technology. This is your opportunity to explore a world of possibilities across areas such as Data & Analytics, Digital, Technology & Innovation, Cybersecurity, R&D Operations, Global Distribution, Finance, Regulatory Affairs, General & Administrative, Human Resources, and many more. Located in the heart of Lisbon, our AMGEN office fosters a culture of innovation, excellence, and purpose. Come thrive with us at AMGEN, supporting our mission To Serve Patients. What we do at AMGEN matters in people's lives.
Amgen is seeking a Transfer Pricing Manager to lead and oversee the global transfer pricing documentation process. This role is responsible for managing the preparation of the OECD Master File and local country files, strengthening audit defense, and supporting global tax risk management. The Transfer Pricing Manager will serve as a key subject matter expert within the tax organization, owning the end-to-end documentation lifecycle and partnering with Finance, Legal, Supply Chain, and business stakeholders to understand and accurately reflect Amgen's evolving business operations in its transfer pricing documentation. The role will also help advance documentation standards, governance processes, stakeholder coordination, and technology-enabled workflows to improve efficiency, consistency, and risk management. While documentation management is the primary responsibility, the role also provides exposure to transfer pricing planning, audit defense, and cross-functional business initiatives. This is a critical role that directly supports Amgen’s global compliance and controversy strategy.
Preferred:
AMGEN is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status. We will ensure that individuals with disabilities are provided a reasonable accommodation to participate in the job application or interview process, to perform crucial job functions, and to receive other benefits and privileges of employment. Please contact us to request an accommodation.
Salary Range 49 790,45 EUR - 67 363,55 EUR
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen